Literature DB >> 15622385

Revision of the CEAP classification for chronic venous disorders: consensus statement.

Bo Eklöf1, Robert B Rutherford, John J Bergan, Patrick H Carpentier, Peter Gloviczki, Robert L Kistner, Mark H Meissner, Gregory L Moneta, Kenneth Myers, Frank T Padberg, Michel Perrin, C Vaughan Ruckley, Philip Coleridge Smith, Thomas W Wakefield.   

Abstract

The CEAP classification for chronic venous disorders (CVD) was developed in 1994 by an international ad hoc committee of the American Venous Forum, endorsed by the Society for Vascular Surgery, and incorporated into "Reporting Standards in Venous Disease" in 1995. Today most published clinical papers on CVD use all or portions of CEAP. Rather than have it stand as a static classification system, an ad hoc committee of the American Venous Forum, working with an international liaison committee, has recommended a number of practical changes, detailed in this consensus report. These include refinement of several definitions used in describing CVD; refinement of the C classes of CEAP; addition of the descriptor n (no venous abnormality identified); elaboration of the date of classification and level of investigation; and as a simpler alternative to the full (advanced) CEAP classification, introduction of a basic CEAP version. It is important to stress that CEAP is a descriptive classification, whereas venous severity scoring and quality of life scores are instruments for longitudinal research to assess outcomes.

Entities:  

Mesh:

Year:  2004        PMID: 15622385     DOI: 10.1016/j.jvs.2004.09.027

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  200 in total

1.  Injection-related venous disease and walking mobility.

Authors:  Barbara Pieper; Thomas N Templin; Robert S Kirsner; Thomas J Birk
Journal:  J Addict Dis       Date:  2010-10

Review 2.  [Diagnosis and treatment of varicose veins. Part 1: definition, epidemiology, etiology, classification, clinical aspects, diagnostic and indications].

Authors:  H Nüllen; T Noppeney
Journal:  Chirurg       Date:  2010-11       Impact factor: 0.955

3.  HFE p.C282Y gene variant is associated with varicose veins in Russian population.

Authors:  Ekaterina A Sokolova; Alexandra S Shadrina; Kseniya S Sevost'ianova; Andrey I Shevela; Evgenii Yu Soldatsky; Evgenii I Seliverstov; Marina Yu Demekhova; Oleg A Shonov; Evgenii A Ilyukhin; Mariya A Smetanina; Elena N Voronina; Igor A Zolotukhin; Maxim L Filipenko
Journal:  Clin Exp Med       Date:  2015-09-28       Impact factor: 3.984

4.  Comparison of high ligation and stripping of the great saphenous vein combined with foam sclerotherapy versus conventional surgery for the treatment of superficial venous varicosities of the lower extremity.

Authors:  Zi-Yuan Zhao; Xiu-Jun Zhang; Jun-Hai Li; Mei Huang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 5.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.

Authors:  Elisabeth MacColl; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-08-28       Impact factor: 4.030

Review 6.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

7.  Itch: association with chronic venous disease, pain, and quality of life.

Authors:  Julia C Paul; Barbara Pieper; Thomas N Templin
Journal:  J Wound Ostomy Continence Nurs       Date:  2011 Jan-Feb       Impact factor: 1.741

8.  Venous ulcers: new options in treatment: minimally invasive vein surgery.

Authors:  Honesto Poblete; Steven Elias
Journal:  J Am Col Certif Wound Spec       Date:  2009-05-01

9.  Study on the efficacy of surgery of the superficial venous system and of compression therapy at early stages of chronic venous disease for the prevention of chronic venous ulceration.

Authors:  Raffaele Serra; Bruno Amato; Lucia Butrico; Andrea Barbetta; Giovanni De Caridi; Mafalda Massara; Francesco G Caliò; Chiara Longo; Gianfranco Dardano; Marco Cannistrà; Gianluca Buffone; Stefano de Franciscis
Journal:  Int Wound J       Date:  2016-05-15       Impact factor: 3.315

10.  Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

Authors:  Suresh Vedantham; Samuel Z Goldhaber; Susan R Kahn; Jim Julian; Elizabeth Magnuson; Michael R Jaff; Timothy P Murphy; David J Cohen; Anthony J Comerota; Heather L Gornik; Mahmood K Razavi; Lawrence Lewis; Clive Kearon
Journal:  Am Heart J       Date:  2013-03-05       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.